Thursday, May 30, 2024
7:00PM – 8:00PM ET
Please note this Clinical Conversation program is 7:00PM Eastern, 6:00PM Central, 5:00PM Mountain and 4:00PM Pacific.
PRESENTING FACULTY
 |
Mario Castro, MD, MPH L.E Phillips and Lenora Carr Phillips Professor Chief, Pulmonary, Critical Care and Sleep Medicine Vice Chair for Clinical and Translational Research Director, Frontiers Clinical and Translational Science Institute at the University of Kansas University of Kansas School of Medicine Kansas City, KS |
 |
Anju T. Peters, MD, MSCI Associate Chief of Clinical Practice and Innovation Division of Allergy and Immunology Director, Center for Clinical Research Northwestern University Clinical and Translational Sciences Institute (NUCATS) Chicago, IL |
PROGRAM OVERVIEW
This virtually live clinical conversation exchange educational series focuses on up-to-date understanding of the latest data in the management of moderate-to-severe asthma in addition to explaining the short and long-term burdens to which chronic OCS leads. Engagement with both a pulmonologist and immunologist through expert, case-based discussion will highlight unique perspectives from each of these specialists on the patient with moderate-to-severe asthma. Discussion will cover immune characterization of asthma patients to the clinical evidence supporting the use of approved and investigational biologics in these challenging populations.
TARGET AUDIENCE
This activity is designed to meet the educational needs of community primary care clinicians, allergists, immunologists, pulmonologists, otolaryngologists (ENT specialists), and other members of the multidisciplinary team to ensure an up-to-date understanding of the latest data in management of moderate-to-severe asthma.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Explain the burden chronic OCS usage imparts on achieving treatment goals, daily QoL, and associated toxicities in managing asthma
- Discuss the clinical evidence for approved and investigational biologics for the treatment of moderate-to-severe asthma
- Detail strategies to improve appropriate referrals to implement multidisciplinary care effectively
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected].
